Introduction

These differences are not procedural overhead added on top of standard product development — they are structural requirements that change how every phase of the development process operates. A standard digital product’s design decisions are governed by user research findings and business objectives. A medical device’s design decisions are governed by the same factors plus the IEC 62366 usability engineering standard, ISO 14971 risk management requirements, and the FDA’s Human Factors guidance for medical devices. Each of these frameworks imposes specific process artifacts — use specification documents, risk management files, formative and summative usability study reports — that must be produced and maintained throughout the development lifecycle as part of the regulatory submission package. Figma supports the design validation phases of medical device development. WCAG 2.1 accessibility standards apply to the software layer of medical devices as a baseline that regulatory standards extend rather than replace. The documentation discipline required for medical device development is not optional — it is the evidence base that regulatory submissions are built from.

How Medical Device Product Development Works

Definition. Medical device product development is a regulated discipline that applies standard product design and engineering practices within a framework of safety-critical documentation requirements — including FDA Human Factors guidance, IEC 62366 usability engineering process artifacts, ISO 14971 risk management documentation, and a design history file that traces every significant design decision from its origin through its validation — producing a device that is both usable and demonstrably safe for its intended use population.

How medical device development differs from standard product development at each phase

• Discovery and use specification — medical device discovery produces a formal Use Specification document defining the intended use, the intended use environment, the intended user population, and the known use-related hazards — a regulatory artifact that standard product discovery does not require
• Risk management throughout design — ISO 14971 requires that risk management be conducted in parallel with design throughout the development lifecycle, with each design decision evaluated against identified risks and mitigation measures documented before the design is finalized
• Formative usability studies — IEC 62366 requires structured usability studies at multiple points during design to evaluate whether users can safely operate the device — not optional prototype testing, but formally documented studies that are part of the regulatory record
• Design history file maintenance — every significant design input, design output, design review, and design validation must be documented in a design history file that demonstrates the design process was controlled and traceable
• Summative validation testing — before a medical device can be submitted for FDA clearance, a formal summative usability study must demonstrate that the intended use population can use the device without unacceptable use-related risk under simulated use conditions

What the Regulatory Framework Adds to Each Development Phase

The regulatory requirements for medical device product development are not a single compliance checkpoint at the end of the design process — they are a continuous thread that runs through every phase and changes how decisions are made, documented, and validated throughout.

Discovery in medical device development produces a formal Use Specification rather than a product brief. The Use Specification defines the intended use of the device, the intended use environment including the physical conditions and distractions present during use, the intended user population including their training level and physical capabilities, and the known hazards associated with foreseeable misuse. This document is not internal team documentation — it is a regulatory artifact that the FDA reviewer will use to evaluate whether the subsequent usability studies were designed to test the right population under the right conditions. A Use Specification that defines the intended user inaccurately produces formative studies that test the wrong population and a regulatory submission that the FDA reviewer can challenge on the basis of population mismatch.

Risk management under ISO 14971 runs continuously through the design phase. Every interface decision — button placement, alert styling, confirmation dialog design — must be evaluated against the risk management file’s list of identified hazards. A design that places a high-consequence action in a location where it could be accidentally triggered by the intended user population under foreseeable use conditions introduces a use-related risk that must either be mitigated by the design or documented as an acceptable residual risk with a supporting risk-benefit analysis. This evaluation is not conducted by a separate risk management team reviewing completed design — it is conducted by the design team as each decision is made, with the evaluation documented in the design history file.

Formative usability studies under IEC 62366 are structured evaluations of the device’s interface at one or more points during design, testing whether representative users from the intended use population can operate the device without producing use errors that could cause harm. These studies are not standard usability tests — they are formally documented research activities with specific participant criteria, task protocols, data collection methods, and findings reports that become part of the regulatory submission. Since 2019, Phenomenon Studio has worked on digital healthcare products including HIPAA-compliant platforms where the documentation discipline of regulated product development applies — the formative study methodology and design history file practices described here reflect the framework that medical device development formally requires.

Conclusion

Medical device product development differs from standard product development through regulatory requirements that make design decisions traceable in a design history file, usability validation formally documented through IEC 62366 studies, risk management continuous under ISO 14971, and every phase of the process oriented toward demonstrating that the device can be used safely by its intended population. These requirements do not replace good product design practice — they extend it with a documentation and validation discipline that makes the design process auditable and the device’s safety defensible. For healthcare technology companies building HIPAA-compliant digital health products, our healthcare app development service covers regulated-sector design and development with documented compliance processes. For teams beginning a healthcare product development cycle with an unclear product scope, our product discovery service establishes the use specification and user research foundation before any design investment begins.